Concerns about blood clots and an FDA –funded study arose in September of 2011 when the suggestion of a 1.5 fold increase in blood clots was shown from drospirenone-containing Birth Control Pills (BCPs).
The FDA has established a new innovation pathway designed to help new end-stage kidney products reach patients more rapidly! The first three to be chosen from 32 others are:
Dr. Rybacki to be a guest on Conversations with Peter Solomon WIP, 94.1 FM April 8th 7:30 AM to 8 AM
I'll be a guest on Conversations with Peter solomon on WIP AM and FM (94.1 FM) in Philadelphia, Sunday, April 8th from 7:30 AM to 8 AM.
European Medicines Agency (EMA) accepts new weight loss drug (Lorques-lorcaserin) for marketing review
Many millions of Americans struggle with weight. Some of us know that QNEXA (phentermine + topiramate) could get the FDA nod as soon as April 17th, but there is another drug which you should know about.
As we've long recommended in the Essential Guide to Prescription Drugs, the best colleague any doctor can have is a more fully informed patient.